AKT1 and ovarian carcinoma: In conclusion, our study confirms the important role of TPTEP1 in ovarian cancer (OC) progression and suggests that TPTEP1 inhibits the PI3K/AKT signalling pathway by directly binding PTBP1, possibly indicating the molecular mechanism underlying its biological function.